Valuation: Adocia

Market Cap 8.1Cr 9.23Cr 7.46Cr 6.95Cr 13Cr 877.12Cr 13Cr 90Cr 35Cr 430.54Cr 35Cr 34Cr 1.5TCr P/E 2026 *
16.7x
P/E 2027 * -10.3x
Enterprise Value 3.22Cr 3.67Cr 2.97Cr 2.77Cr 5.21Cr 349.08Cr 5.32Cr 36Cr 14Cr 171.35Cr 14Cr 13Cr 596.33Cr EV / Sales 2026 *
0.84x
EV / Sales 2027 * -0.71x
Free-Float
89.7%
Yield 2026 *
-
Yield 2027 * -
1 day+0.63%
1 week+1.36%
Current month+0.63%
1 month-15.57%
3 months-10.98%
6 months-37.82%
Current year-37.82%
1 week 3.87
Extreme 3.87
4.28
1 month 3.87
Extreme 3.87
4.88
Current year 3.87
Extreme 3.87
7.45
1 year 3.62
Extreme 3.62
12.4
3 years 2.86
Extreme 2.86
16.16
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
62.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Date Insider Type Main position Quantity % Market Cap.
27/25/27Buy

Founder

1,09,170 0.6972%
06/24/06Buy

Founder

15,576 0.1105%
06/24/06Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%+1.36%+12.59%+5.20% 9.25Cr
-2.19%+6.01%+66.90%+127.13% 5.76TCr
+0.55%+17.77%+80.01%+100.93% 5.51TCr
+0.98%+3.92%-12.80%-13.05% 2.35TCr
+0.51%+3.65%+9.85%+416.80% 2.31TCr
-1.93%+11.11%+34.89%-7.86% 1.81TCr
+0.28%+5.51%+36.93%-30.58% 1.68TCr
-0.54%+2.31%+24.00%+182.75% 1.37TCr
+0.14%+9.60%+33.31% - 1.3TCr
-3.87%+1.25%+71.95%+128.60% 1.24TCr
Average -0.55%+5.07%+35.77%+101.10% 2.34TCr
Weighted average by Cap. -0.63%+4.62%+47.54%+116.31%

Financials

2026 *2027 *
Net sales 3.84Cr 4.37Cr 3.53Cr 3.29Cr 6.21Cr 415.67Cr 6.34Cr 42Cr 16Cr 204.03Cr 16Cr 16Cr 710.09Cr 1.48Cr 1.68Cr 1.36Cr 1.27Cr 2.39Cr 159.73Cr 2.43Cr 16Cr 6.33Cr 78Cr 6.31Cr 6.17Cr 272.87Cr
Net income 39.76L 45.29L 36.6L 34.1L 64.32L 43Cr 65.63L 4.4Cr 1.71Cr 21Cr 1.7Cr 1.66Cr 74Cr -80.08L -91.21L -73.71L -68.69L -1.3Cr -87Cr -1.32Cr -8.87Cr -3.44Cr -43Cr -3.42Cr -3.35Cr -148.14Cr
Net Debt -4.88Cr -5.55Cr -4.49Cr -4.18Cr -7.89Cr -528.05Cr -8.05Cr -54Cr -21Cr -259.2Cr -21Cr -20Cr -902.07Cr -9.15Cr -10Cr -8.42Cr -7.85Cr -15Cr -990.48Cr -15Cr -101.27Cr -39Cr -486.18Cr -39Cr -38Cr -1.69TCr
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
01/26/01 4.166 +0.63% 1,64,535
30/26/30 €4.140 +1.92% 1,83,846
29/26/29 €4.062 -3.97% 1,77,755
26/26/26 €4.230 +7.41% 1,36,263
25/26/25 €3.938 -1.60% 1,02,674
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.140EUR
Average target price
13.00EUR
Spread / Average Target
+214.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock